Literature DB >> 11733001

ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).

T Yamochi1, K Semba, K Tsuji, K Mizumoto, H Sato, Y Matsuura, I Nishimoto, M Matsuoka.   

Abstract

p70ik3-1 (a 70-kDa protein) contains a cyclin box, and binds to p35cdk3 in vivo and in vitro [Matsuoka, M., Matsuura, Y., Semba, K. & Nishimoto, I. (2000) Biochem. Biophys. Res. Commun. 273, 442-447]. In spite of its structural similarity to cyclins, p70ik3-1 does not activate cyclin-dependent kinase 3 (cdk3)-mediated phosphorylation of pRb, histone H1, or the C-terminal domain of RNA polymerase II. Here, we report that Ser274 of p70ik3-1 is phosphorylated by cdk2 or cdk3 bound to cyclin A and to cyclin E in vitro. We also found that in COS7 cells in which cyclin E and cdk3 were ectopically overexpressed, the phosphorylation level of Ser274 in coexpressed p70ik3-1 is upregulated. We therefore conclude that p70ik3-1 is a substrate for cdk3-mediated phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733001     DOI: 10.1046/j.0014-2956.2001.02555.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation.

Authors:  Yong-Yeon Cho; Faqing Tang; Ke Yao; Chengrong Lu; Feng Zhu; Duo Zheng; Angelo Pugliese; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

3.  Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease.

Authors:  Laura C Hernández-Ramírez; Ryhem Gam; Nuria Valdés; Maya B Lodish; Nathan Pankratz; Aurelio Balsalobre; Yves Gauthier; Fabio R Faucz; Giampaolo Trivellin; Prashant Chittiboina; John Lane; Denise M Kay; Aggeliki Dimopoulos; Stephan Gaillard; Mario Neou; Jérôme Bertherat; Guillaume Assié; Chiara Villa; James L Mills; Jacques Drouin; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-05-22       Impact factor: 5.678

4.  Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.

Authors:  T Xiao; J J Zhu; S Huang; C Peng; S He; J Du; R Hong; X Chen; A M Bode; W Jiang; Z Dong; D Zheng
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

5.  CABLES1 Deficiency Impairs Quiescence and Stress Responses of Hematopoietic Stem Cells in Intrinsic and Extrinsic Manners.

Authors:  Liang He; Florian Beghi; Viviane Baral; Mallorie Dépond; Yanyan Zhang; Virginie Joulin; Bo R Rueda; Patrick Gonin; Adlen Foudi; Monika Wittner; Fawzia Louache
Journal:  Stem Cell Reports       Date:  2019-07-18       Impact factor: 7.765

6.  Disruption of entire Cables2 locus leads to embryonic lethality by diminished Rps21 gene expression and enhanced p53 pathway.

Authors:  Tra Thi Huong Dinh; Hiroyoshi Iseki; Seiya Mizuno; Saori Iijima-Mizuno; Yoko Tanimoto; Yoko Daitoku; Kanako Kato; Yuko Hamada; Ammar Shaker Hamed Hasan; Hayate Suzuki; Kazuya Murata; Masafumi Muratani; Masatsugu Ema; Jun-Dal Kim; Junji Ishida; Akiyoshi Fukamizu; Mitsuyasu Kato; Satoru Takahashi; Ken-Ichi Yagami; Valerie Wilson; Ruth M Arkell; Fumihiro Sugiyama
Journal:  Elife       Date:  2021-05-05       Impact factor: 8.140

7.  CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/β-catenin pathway.

Authors:  Ting Cao; Tian Xiao; Guanqun Huang; Yafei Xu; Joe Jiang Zhu; Kaixin Wang; Wencai Ye; Hong Guan; Jinsong He; Duo Zheng
Journal:  Oncotarget       Date:  2017-05-25

8.  Characterization of a bicistronic knock-in reporter mouse model for investigating the role of CABLES2 in vivo.

Authors:  Ammar Shaker Hamed Hasan; Tra Thi Huong Dinh; Hoai Thu Le; Saori Mizuno-Iijima; Yoko Daitoku; Miyuki Ishida; Yoko Tanimoto; Kanako Kato; Atsushi Yoshiki; Kazuya Murata; Seiya Mizuno; Fumihiro Sugiyama
Journal:  Exp Anim       Date:  2020-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.